2 completed, 1 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
Follow Ovarian gynandroblastoma: new trials by email Literature Review of Ovarian gynandroblastoma trials Research Report on Ovarian gynandroblastoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors Bleomycin Sulfate, Carboplatin, Cisplatin - Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma | Phase 2 | Unknown | GOG Foundation | 63 | 2010-02-08 | 2022-01-25 |
| Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary Bevacizumab, Laboratory Biomarker Analysis - Malignant Ovarian Epithelial Tumor, Ovarian Granulosa Cell Tumor | Phase 2 | Completed | National Cancer Institute (NCI) | 36 | 2008-09-22 | 2019-07-23 |
| Paclitaxel in Treating Patients With Ovarian Stromal Cancer Paclitaxel - Adult Type Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma | Phase 2 | Completed | Gynecologic Oncology Group | 31 | 2000-11-20 | 2020-03-05 |
Sertoli-Leydig Cell Tumor (3) · Granulosa cell tumor of the ovary (2)
Adnexal Diseases (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Diseases, Male (3) · Genital Neoplasms, Female (3) · Genital Neoplasms, Male (3) · Gonadal Disorders (3) · Male Urogenital Diseases (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3)
Paclitaxel (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Bevacizumab (1) · Bleomycin (1) · Carboplatin (1) · Cisplatin (1) · Disulfides (1) · Immunoglobulin G (1) · Platinum (1) · Taxes (1) · etoposide phosphate (1)
GOG Foundation (1) · Gynecologic Oncology Group (1) · National Cancer Institute (NCI) (1)
United States (3) · Japan (1)
Jubilee Brown (2) · Linda Van Le (1)
U10CA027469 (3), U10CA180868 (3)